One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Healthcare ➤ Histology and Cytology Market
Histology and Cytology Market
Histology and Cytology Market
Published date: Feb 2024 • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Healthcare ➤ Histology and Cytology Market

Global Histology and Cytology Market By Type Of Examination, Histology-By Technique(Microscopy, Immunohistochemistry, Molecular Pathology, Cryostat & Microtomy) Cytology-By Technique(Microscopy, Immunohistochemistry, Molecular Pathology, Cryostat & Microtomy) By Product(Instruments And Analysis Software System, Consumable And Reagents) By Application (Drug Discovery & Designing, Clinical Diagnostics, Point-of-Care (PoC), Non-Point-of-Care, Research) By End User (Hospitals, Diagnostic Centers, Biotechnology and Pharmaceutical Industry, Other End Users) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: Feb 2024
  • Report ID: 58874
  • Number of Pages: 266
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Market Overview
    • Key Takeaways
    • Types of Examination Analysis
    • Product Analysis
    • Application Analysis
    • End User Analysis
    • Key Market Segments
    • Regional Analysis
    • Key Regions and Countries
    • Market Players Analysis
    • Маrkеt Kеу Рlауеrѕ
    • Recent Developments
    • Report Scope

    Market Overview

    The Global Histology and Cytology Market size is expected to be worth around USD 70.1 Billion by 2033 from USD 18.1 Billion in 2023, growing at a CAGR of 14.5% during the forecast period from 2024 to 2033.

    Cytology involves studying cell structure, function and overall understanding within life sciences while histology examines microscopic anatomy of living organisms’ cells and tissues. Both disciplines aim to unravel the complex structures of animal and plant tissues at microscopic scale. Cytology stands out due to its rapid examination pace, precise results and cost-efficiency. Histology and cytology remain critical diagnostic tools that play an important role in screening tests to detect disease; their increased use has only amplified their relevance further. Histology and cytology serve as invaluable diagnostic tools in the detection of various infectious and cell-related conditions including cervical issues, inflammation disorders, cancer diagnosis as well as autoimmunity conditions.

    Additionally, digital cytology systems are being developed by companies to aid in rapid evaluations of cytology samples. Antech Diagnostics, for example, introduced the North American Digital Cytology Scanner, in June 2021. This scanner delivers whole-slide interpretations in less than 2 hours. It also allows you to assess large quantities of samples at POC settings and reduces the time it takes to examine them.

    Major factors that will drive the market over the forecast period include an increase in demand for the detection of cell and tissue characteristics and a global rise in the incidence of cell-based diseases like cancer. Integration of digital solutions in cytological diagnosis gives the advantage of the quick interpretation of primary diagnostic data. This market is growing due to immunohistochemistry’s increasing popularity for visualizing cells to diagnose a variety of diseases including cancers. Innovative immunohistochemistry instruments are being developed by a number of companies.

    Histology and Cytology Market Size

    Key Takeaways

    • Market Size: Histology and Cytology Market size is expected to be worth around USD 70.1 Billion by 2033 from USD 18.1 Billion in 2023.
    • Market Growth: The market growing at a CAGR of 14.5% during the forecast period from 2024 to 2033.
    • Types of Examination Analysis: The market leader was cytology, with a 71% revenue share in 2023.
    • Product Analysis: Consumables and reagents were the dominant segments by 60% market share in 2023.
    • Application Analysis: The segment of drug discovery and design dominated by 48% this market in 2023.
    • End-Use Analysis: Hospitals dominate the Histology and Cytology Market with 34% market share.
    • Regional Analysis: North America held the largest market share with over 41.1% in 2023.

    Types of Examination Analysis

    The market leader was cytology, with a 71% revenue share in 2023, which is expected to continue throughout the forecast period. The segment’s growth is due to the use of AI for developing advanced systems. Hologic Inc., for example, partnered with Google Cloud to integrate machine-learning technologies into its Genius Digital Diagnostics System in February 2021. This agreement aims at improving cervical cancer screening using machine learning, and Artificial Intelligence.

    Early screening and detection are the keys to improving your chances of catching breast cancer. Fine Needle Aspiration Cytology, also known as FNAC, is the best way to detect breast carcinoma. FNAC is vital for the preoperative pathological evaluation and management of breast cancer.

    Fine needle aspiration cytology, which is operator-dependent, is more difficult than histological analysis. Due to the relatively high incidence of breast cancer, countries with low and middle incomes are a good place for new industry participants looking to establish a market presence. It is therefore essential to reduce the mortality rate by using effective screening methods.

    Papanicolaou (Pap smear), is recommended by WHO for cervical screening. This method detects cervical cancerous precursors at low cost and high rates. The market will grow if there is an increase in innovative cytology solutions for cervical cancer screening.

    Modern histology technology has facilitated workflow and increased diagnostic capabilities for clinical laboratories. In addition, many companies are now focusing their efforts on integrating AI platforms into histology. Cernostics in partnership with Deciphex evaluated AI technology-based imaging tools in order to facilitate the early detection of Barrett’s esophageal cancer.

    Product Analysis

    Consumables and reagents were the dominant segments by 60% market share in 2023. It is expected that the segment will continue growth from 2023 to 2032. There are many consumables that are used in the histology or cytology process, including tissue sample containers and kits, fixatives, medium reagents, stain solutions, and others. The routine adoption of histology or cytology consumables is responsible for segment growth. Additionally, companies are creating cost-effective reagents and kits that will further drive the market in cytology/histology.

    Biocare Medical LLC released the TIGIT [BLR047F] rabbit monoclonal antibody in collaboration with Bethyl Laboratories. It allows qualitative identification of TIGIT proteins by Immunohistochemistry. The antibody will provide a cost-effective immunohistochemistry option for institutions involved in biotech and pharmaceutical research.

    Due to the increased use of technologically advanced instruments like multimodal nonlinear microscopes, photoacoustic microscopic microscopy, and stimulated Raman spectroscopy for histopathology, the instruments, and analysis system segment will see a significant increase in growth between 2023-2032. However, the large-scale adoption of digital transformational solutions in pathology has been hindered by high infrastructure costs as well as technical and practical limitations. Therefore, digitization costs will decrease in pathology.

    Application Analysis

    With a 48%  revenue share, the segment of drug discovery and design dominated this market in 2023. It is expected that the segment will maintain its leadership position during the forecast period. The large use of IHC staining in drug development companies and pharmaceutical companies can explain the segment’s growth. Image analysis is used across many steps of drug discovery, development, and validation such as target validation, drug efficacy, safety studies, drug repositioning, and patient stratification.

    The growing use of histopathology for the diagnosis of various types of cancer is expected to drive a 13.5% CAGR in the clinical diagnostics segment. To identify abnormalities and malignancy, the cells and tissues of suspicious lump sites are removed. They are widely used in the screening of different types of cancer, including cervical, breast, and bowel cancer.

    End User Analysis

    Hospitals dominate the Histology and Cytology Market with 34% market share, using histology and cytology techniques for accurate patient assessments using state-of-the-art laboratories, skilled professionals and providing comprehensive histopathology/cytopathology services that address various healthcare needs.

    Diagnostic centers also play a vital role in the market by offering histology and cytology services directly to patients. Their primary mission is delivering quick diagnostic results quickly to enable timely medical intervention for enhanced patient outcomes.

    Biotechnology and pharmaceutical industries also contribute significantly to the histology and cytology market growth, using histology/cytology techniques for drug development, efficacy testing, safety assessments, as well as advancements in medical research/therapeutics.

    Histology and Cytology Market Share

    Key Market Segments

    Type Of Examination

    Histology

    By Technique

    • Microscopy
    • Immunohistochemistry
    • Molecular Pathology
    • Cryostat & Microtomy

    Cytology

    By Technique

    • Microscopy
    • Immunohistochemistry
    • Molecular Pathology
    • Cryostat & Microtomy

    Product

    • Instruments And Analysis Software System
    • Consumable And Reagents

    Application

    • Drug Discovery & Designing
    • Clinical Diagnostics
    • Point-of-Care (PoC)
    • Non-Point-of-Care
    • Research

    End User

    • Hospitals
    • Diagnostic Centers
    • Biotechnology and Pharmaceutical Industry
    • Other End Users

    Regional Analysis

    North America held the largest market share with over 41.1% in 2023. Many factors contributed to the region’s growth, such as high cancer incidence, extensive R&D, key players, and a well-established research infrastructure for pathology. Additionally, the market is thriving due to the high rate at which products are approved and commercialized in the region.

    The Asia Pacific is expected to see the fastest growth in the market for cytology and histology between 2024-2033. Many factors have contributed to the rapid growth of this market, such as rising cancer awareness, large target populations, and improved healthcare infrastructure. Research is also accelerating the growth of this market by evaluating new forms of cytology.

    In Japan, researchers evaluated the efficacy and safety of liquid-based Cytology in cervical cancer screening in February 2021. The study revealed that liquid-based, practical cytology was superior to conventional cytology.

    Histology and Cytology Market Region

    Key Regions and Countries

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Russia
      • Spain
      • Rest of Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • MEA
      • GCC
      • South Africa
      • Israel
      • Rest of MEA

    Market Players Analysis

    Different solutions for cancer screening have had rapid introductions and approvals in recent years. Hologic Inc. was granted premarket approval in May 2021 by the U.S. FDA to market its Thin Prep Genesis Processor. The Thin Prep genesis processor combines sample processing and cytology with improved workflow.

    Barcode scanning, automatic tube, and slide labeling are some of the features. These features reduce hands-on work and allow for repetitive motions. The company offers a large selection of products and automated testing platforms to detect cervical cancer.

    Маrkеt Kеу Рlауеrѕ

    • Hologic, Inc.
    • BD
    • Abbott
    • Merck KgaA
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • Trivitron Healthcare
    • Sysmex Corporation
    • Koninklijke Philips N.V.

    Recent Developments

    • January 2024: Hologic, Inc. Received FDA clearance for the Panther Fusion Aptima HSV 1 & 2 Assay, a molecular diagnostic test for herpes simplex virus.
    • February 2024: BD Launched the BD Accuri Cytoflex LX flow cytometer with advanced automation features.
    • November 2023: Abbott Announced a partnership with Microsoft to develop AI-powered solutions for pathology workflows.
    • December 2023: Merck KGaA Signed a collaboration agreement with Incellerate to develop AI-based digital pathology solutions.

    Report Scope

    Report Features Description
    Market Value (2023) USD 70.1 Billion
    Forecast Revenue (2033) USD 18.1 Billion
    CAGR (2024-2033) 14.5%
    Base Year for Estimation 2023
    Historic Period 2018-2022
    Forecast Period 2024-2033
    Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments
    Segments Covered By Type Of Examination, Histology-By Technique(Microscopy, Immunohistochemistry, Molecular Pathology, Cryostat & Microtomy) Cytology-By Technique(Microscopy, Immunohistochemistry, Molecular Pathology, Cryostat & Microtomy) By Product(Instruments And Analysis Software System, Consumable And Reagents) By Application (Drug Discovery & Designing, Clinical Diagnostics, Point-of-Care (PoC), Non-Point-of-Care, Research) By End User (Hospitals, Diagnostic Centers, Biotechnology and Pharmaceutical Industry, Other End Users)
    Regional Analysis North America-US, Canada, Mexico;Europe-Germany, UK, France, Italy, Russia, Spain, Rest of Europe;APAC-China, Japan, South Korea, India, Rest of Asia-Pacific;South America-Brazil, Argentina, Rest of South America;MEA-GCC, South Africa, Israel, Rest of MEA
    Competitive Landscape Hologic, Inc., BD, Abbott, Merck KgaA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Danaher, Trivitron Healthcare, Sysmex Corporation, Koninklijke Philips N.V.
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)

    Frequently Asked Questions (FAQ)

    What is histology?

    Histology is the study of the microscopic anatomy of tissues and cells in living organisms.

    What is cytology?

    Cytology is the study of the structure, function, and understanding of cells within the realm of life sciences.

    How big is the Histology and Cytology Market?

    The global Histology and Cytology Market size was estimated at USD 18.1 Billion in 2023 and is expected to reach USD 70.1 Billion in 2033.

    What is the Histology and Cytology Market growth?

    The global Histology and Cytology Market is expected to grow at a compound annual growth rate of 14.5%. From 2024 To 2033

    Who are the key companies/players in the Histology and Cytology Market?

    Some of the key players in the Histology and Cytology Markets are Hologic, Inc., BD, Abbott, Merck KgaA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Danaher, Trivitron Healthcare, Sysmex Corporation, Koninklijke Philips N.V.

    What do histology and cytology aim to explain?

    Both histology and cytology strive to elucidate the structure of animal and plant tissues and cells, particularly at the microscopic level.

    Why is cytology popular?

    Cytology is popular due to its rapid examination rate, precision, affordability, and its significant utility in cervix screening tests.

    What disorders are investigated using histology and cytology?

    Histology and cytology are instrumental in diagnosing numerous infectious and cell-based disorders, including cervical diseases, inflammatory diseases, cancer, and autoimmune diseases.

    Histology and Cytology Market
    Histology and Cytology Market
    Published date: Feb 2024
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Hologic, Inc.
    • Becton, Dickinson and Company Profile
    • Abbott Laboratories
    • Merck KGaA Company Profile
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific, Inc.
    • Danaher Corporation Company Profile
    • Trivitron Healthcare
    • Sysmex Corporation
    • Koninklijke Philips N.V.
  • settingsSettings

Related Reports

  • Bioprosthetics Market
  • Muscle Stimulator Market
  • Recombinant Human Serum Albumin Market
  • Tissue and Organ Transplantation Market
  • Artificial Disc Replacement Market
  • Healthcare Additive Market
  • Artificial Organ And Bionics Market
  • Medical Digital Imaging Systems Market

Our Clients

  • Our Clients
Inquiry Before Buying

Histology and Cytology Market
  • 58874
  • Feb 2024
    • ★★★★★
      ★★★★★
    • (42)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.